{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibmhrf3py722jqw545psjnb35wbdepnmwfpykqbxap7bzzr4bl3hi",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mfmwowyhxax2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreif536lna466medshf2almkoavpcgfeaxmsk3yrqofpvhth2yehhn4"
    },
    "mimeType": "image/jpeg",
    "size": 119344
  },
  "path": "/2026/02/24/novo-nordisk-weight-loss-drug-price-cut-examined/?utm_campaign=rss",
  "publishedAt": "2026-02-24T19:41:15.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharma",
    "biotechnology",
    "Novo Nordisk",
    "Obesity",
    "Pharmaceuticals",
    "STAT+",
    "weight loss"
  ],
  "textContent": "Will Novo Nordisk’s slashing of obesity drug prices save patients’ money or expand access? It depends.",
  "title": "STAT+: Will Novo Nordisk’s slashing of obesity drug prices save patients’ money? It depends",
  "updatedAt": "2026-02-24T19:41:19.000Z"
}